Healio (12/13, Gramigna) reports, “Available evidence does not sufficiently support prescription cannabinoids for treating psychiatric disorders,” researchers concluded after conducting an 841-study review, the findings of which were published online Dec. 8 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.
Related Links:
— “Current evidence does not support prescription cannabinoids for psychiatric disorders “Joe Gramigna, Healio, December 13, 2021